[Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis].
Mikhail MelnikovAnastasia SviridovaT V SolodovaA V LopatinaM V PashenkovAlexey BoykoPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
Dopamine and blockade of D1-like dopaminergic receptors have an inhibitory effect on Th17-cell function in MS. The activation of D2-like dopaminergic receptors could mediate the inhibitory effect of dopamine on Th17-cells.